Cited by 598Mitochondrial Function and PathologyAlzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

The DOI matches its Crossref record.

Cytochrome oxidase deficiency in Alzheimer’s disease

Parker, William Davis, Filley, Christopher M., Parks, Janice K.·1990·Neurology

DOI 10.1212/wnl.40.8.1302

Open this paper in CoChat — free account

Abstract

We assayed cytochrome oxidase and other electron transport chain activities in platelet mitochondria isolated from patients with Alzheimer's disease (AD). Five of 6 patients had striking reductions of platelet cytochrome oxidase activity (patient mean, 83.72 +/- 82.99 nmol/min/mg; control mean, 167.14 +/- 36.21 nmol/min/mg; n = 8). Other electron transport chain catalytic activities were not significantly different than control values. AD may be a systemic illness, a primary defect in cytochrome oxidase may be pathogenically important in its production, and the mitochondrial genes encoding cytochrome oxidase subunits may be important in producing the defect.

Integrity signals

Registry

Crossref · 10.1212/wnl.40.8.1302

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Sorted by citations

Items 401–500 of 597

Does mitochondrial respiratory chain dysfunction have a role in common neurodegenerative disorders?
Byrne, E. (2002) · Journal of Clinical Neuroscience · doi:10.1054/jocn.2001.0991 · Cited by 24
Controlled and Impaired Mitochondrial Quality in Neurons: Molecular Physiology and Prospective Pharmacology
Matić, I., Strobbe, D., Frison, M., & Campanella, M. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.03.021 · Cited by 23
Mitochondrial Regulatory Pathways in the Pathogenesis of Alzheimer’s Disease
Adiele, R. C., & Adiele, C. A. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150967 · Cited by 23
“Maintenance of optimum neuronal energy (ATP) balance is confined to mitochondrial turnover as well as the proteins of mitochondrial ETC complex I–IV and those of tricarboxylic acid cycle (TCA), some of which are depleted in AD [41, 42].”
Alzheimer's disease in women
Filley, C. M. (1997) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(97)80003-8 · Cited by 23
Self-citation
Acetyl‐l‐Carnitine: A Drug Able to Slow the Progress of Alzheimer's Disease?
Carta, A., & Calvani, M. (1991) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1991.tb00223.x · Cited by 23
Disruption of mitochondrial functions and oxidative stress contribute to neurologic dysfunction in organic acidurias
Wajner, M., Vargas, C. R., & Amaral, A. U. (2020) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2020.108646 · Cited by 24
Mitochondrial defects: An emerging theranostic avenue towards Alzheimer's associated dysregulations
Mani, S., Swargiary, G., Singh, M., Agarwal, S., Dey, A., Ojha, S. K., & Jha, N. K. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119985 · Cited by 24
Mitochondrial DNA Rearrangement Spectrum in Brain Tissue of Alzheimer’s Disease: Analysis of 13 Cases
Chen, Y., Liu, C., Parker, W. D., Chen, H., Beach, T. G., Liu, X., Serrano, G. E., Lu, Y., Huang, J., Yang, K., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154582 · Cited by 21
Self-citation
Human Diseases with Defects in Oxidative Phosphorylation
Schägger, H., & Ohm, T. G. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.0916p.x · Cited by 21
Cytochrome oxidase deficiency: progress and problems
DiMauro, S., Hirano, M., Bonilla, E., Moraes, C. T., & Schon, E. A. (1994) · Elsevier eBooks · doi:10.1016/b978-0-7506-0585-4.50010-1 · Cited by 24
Therapeutic Potential of Heterocyclic Compounds Targeting Mitochondrial Calcium Homeostasis and Signaling in Alzheimer’s Disease and Parkinson’s Disease
Tapias, V., González-Andrés, P., Fernández-Peña, L., Barbero, A., Núñez, L., & Villalobos, C. (2023) · Antioxidants · doi:10.3390/antiox12061282 · Cited by 21
“However, the most common feature observed in AD is a deficiency in mitochondrial complex IV (CYT C oxidase, COX), which has been reported in the cortical and hippocampal brain regions and platelets of patients [4,5].”
Background
Common defects of mitochondria and iron in neurodegeneration and diabetes (MIND): A paradigm worth exploring
Stroh, M. A., Swerdlow, R. H., & Zhu, H. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.11.022 · Cited by 20
“Reduced complex IV activity was first reported in mitochondria isolated from AD subject platelets [105].”
15 Glutathione in the Nervous System: Roles in Neural Function and Health and Implications for Neurological Disease
Janáky, R., Cruz-Aguado, R., Oja, S. S., & Shaw, C. (2007) · Springer eBooks · doi:10.1007/978-0-387-30373-4_15 · Cited by 20
Pharmacotherapy of Cognitive Impairment in Alzheimer's Disease: A Review
Patel, S. (1995) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/089198879500800202 · Cited by 19
Genetic algorithm for analysis of mutations in Parkinson's disease
Smigrodzki, R. M., Goertzel, B., Pennachin, C. L., Coelho, L. D. S., Prosdocimi, F., & Parker, W. D. (2005) · Artificial Intelligence in Medicine · doi:10.1016/j.artmed.2004.11.006 · Cited by 19
“Our results have implications for both PD and for other disorders where heteroplasmic mtDNA mutations may be important, such as sporadic Alzheimer’s disease [22,23].”
ResultSelf-citation
Analysis of the genes coding for subunit 10 and 15 of cytochrome c oxidase in Alzheimer’s disease
Vitali, M. A., Venturelli, E., Galimberti, D., Gatta, L. B., Scarpini, E. A., & Finazzi, D. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0324-8 · Cited by 19
“In particular, the activity of cytochrome c oxidase (COX) (Mutisya et al. 1994; Maurer et al. 2000; Parker et al. 1990, 1994) and a-ketoglutarate dehydrogenase (Mastrogiacomo et al.1993; Gibson et al. 2000; Ko et al. 2001) are markedly reduced, leading to increased generation of reactive oxygen…”
Background
Alzheimer's disease, kuf's disease, tellurium and selenium
Larner, A. J. (1996) · Medical Hypotheses · doi:10.1016/s0306-9877(96)90440-5 · Cited by 19
Mitochondrial function in Alzheimer's disease
Cooper, J. M., Wischik, C. M., & Schapira, A. H. V. (1993) · The Lancet · doi:10.1016/0140-6736(93)91269-r · Cited by 19
Effect of CDP‐choline treatment on mitochondrial and synaptosomal protein composition in different brain regions during aging
Villa, R. F., Ingrao, F., Magri, G., et al. (1993) · International Journal of Developmental Neuroscience · doi:10.1016/0736-5748(93)90037-e · Cited by 19
Expression Changes in Mitochondrial Genes Affecting Mitochondrial Morphology, Transmembrane Potential, Fragmentation, Amyloidosis, and Neuronal Cell Death Found in Brains of Alzheimer’s Disease Patients
Castora, F. J., Kerns, K. A., Pflanzer, H. K., Hitefield, N. L., Gershon, B. S., Shugoll, J., Shelton, M. G., & Coleman, R. A. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220161 · Cited by 18
Free Radical Injury in Skin Cultured Fibroblasts from Alzheimer's Disease Patients
Tesco, G., Latorraca, S., Piersanti, P., Sorbi, S., Piacentini, S., & Amaducci, L. A. (1992) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1992.tb27446.x · Cited by 18
Chronic Mitochondrial Inhibition Induces Glutamate-Mediated Corticomotoneuron Death in an Organotypic Culture Model
van Westerlaak, M. G. H., Joosten, E. A. J., Gribnau, A. A. M., Cools, A. R., & Bär, P. R. (2001) · Experimental Neurology · doi:10.1006/exnr.2000.7570 · Cited by 18
Melatonin as a Guardian of Mitochondria: Mechanisms and Therapeutic Potential in Neurodegenerative Diseases
Bao, Y., Miao, G., He, N., Bao, X., Shi, Z., Hu, C., Liu, X., Wang, B., & Sun, C. (2026) · Biology · doi:10.3390/biology15020189 · Cited by 18
“For instance, significantly reduced activity of Complex IV has been observed in the cerebral cortex of AD patients as early as the initial stages [68].”
Biochemical Studies of Poly-T Variants in the Alzheimer's Disease Associated TOMM40 Gene
Hedskog, L., Brohede, J., Wiehager, B., Pinho, C. M., Revathikumar, P., Lilius, L., Glaser, E. G., Graff, C., Karlström, H., & Ankarcrona, M. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120580 · Cited by 17
“All rights reserved This article is published online with Open Access and distributed under the terms of the Creative Commons Attribution Non-Commercial License. of varying length in the intron between exon 6 and 7 (Fig.”
Background
The Role of Mitochondrial Genes in Neurodegenerative Disorders
Kumar, R., Harilal, S., Parambi, D. G. T., Kanthlal, S. K., Rahman, M. A., Alexiou, A. T., Batiha, G. E., & Mathew, B. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210908163839 · Cited by 16
“Regarding the mitochondrial respiratory chain, mitochondrial complex IV activity has been seen reduced in the AD brain's cortical tissue [94, 95], which can be linked to AD brain hypometabolism [96, 97].”
Mitochondrial Complex I Inhibition Accelerates Amyloid Toxicity
Joh, Y., & Choi, W. (2017) · Development & Reproduction · doi:10.12717/dr.2017.21.4.417 · Cited by 16
“In addition, free radical production, lipid peroxidation, oxidative DNA damage and oxidative protein damage was increased but ATP production and cell viability was decreased in postmortem AD brains (Parker et al., 1990; Smith et al., 1996; Gibson & Huang, 2002; Maurer et al., 2002).”
Background
Ras-ERK-ETS inhibition alleviates neuronal mitochondrial dysfunction by reprogramming mitochondrial retrograde signaling
Duncan, O. F., Granat, L., Ranganathan, R., Singh, V. K., Mazaud, D., Fanto, M., Chambers, D. J., Ballard, C. G., & Bateman, J. M. (2018) · PLoS Genetics · doi:10.1371/journal.pgen.1007567 · Cited by 17
Alzheimer skin fibroblasts show increased susceptibility to free radicals
Tesco, G., Latorraca, S., Piersanti, P., Piacentini, S., Amaducci, L. A., & Sorbi, S. (1992) · Mechanisms of Ageing and Development · doi:10.1016/0047-6374(92)90129-2 · Cited by 17
Mitochondrial dysfunction in diabetes mellitus
Anderson, C. M. (1999) · Drug Development Research · doi:10.1002/(sici)1098-2299(199901)46:1 · Cited by 18
The impact of diabetes on CNS
Kaur, G., & Bhardwaj, S. K. (1998) · Molecular and Chemical Neuropathology · doi:10.1007/bf02815119 · Cited by 17
Morphology‐Specific Inhibition of β‐Amyloid Aggregates by 17β‐Hydroxysteroid Dehydrogenase Type 10
Aitken, L., Quinn, S. D., Pérez‐González, C., Samuel, I. D. W., Penedo, J. C., & Gunn‐Moore, F. J. (2016) · ChemBioChem · doi:10.1002/cbic.201600081 · Cited by 16
Therapeutical Management and Drug Safety in Mitochondrial Diseases—Update 2020
Gruosso, F., Montano, V., Simoncini, C., Siciliano, G., & Mancuso, M. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm10010094 · Cited by 16
“Mitochondrial dysfunction may also be found in neurodegenerative disorders that are not classified as “primary mitochondrial diseases”, such as Alzheimer ́s disease, in which the role of mitochondria is one of the major factors in disease progression [6,7].”
Background
Oxygen Sensing and Signaling in Alzheimer’s Disease: A Breathtaking Story!
Correia, S. C., & Moreira, P. I. (2021) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01148-6 · Cited by 14
Pharmacologic enrichment of exosome yields and mitochondrial cargo
Wang, X., Berkowicz, A., King, K., Menta, B. W., Gabrielli, A. P., Novikova, L., Troutwine, B., Pleen, J., Wilkins, H., & Swerdlow, R. H. (2022) · Mitochondrion · doi:10.1016/j.mito.2022.04.001 · Cited by 16
Alzheimer’s disease: A hypothesis on pathogenesis
Harman, D. (2000) · AGE · doi:10.1007/s11357-000-0017-6 · Cited by 16
The βA4 Amyloid Protein Precursor in Human Circulationa
Bush, A. I., Beyreuther, K. T., & Masters, C. L. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb23048.x · Cited by 16
Mitochondrial DNA A4336G Mutation in Alzheimer’s and Parkinson’s Diseases
Garcia-Lozano, J. R., Mir, P., Alberca, R., Aguilera, I., Néciga, E. G., Fernández-López, O., Cayuela, A., & Núñez‐Roldán, A. (2002) · European Neurology · doi:10.1159/000064955 · Cited by 16
Mitochondrial DNA variants in inclusion body myositis
Kok, C. C., Boyt, A., Gaudieri, S., et al. (2000) · Neuromuscular Disorders · doi:10.1016/s0960-8966(00)00144-9 · Cited by 16
Decoding Cancer through Silencing the Mitochondrial Gatekeeper VDAC1
Arif, T., Shteinfer‐Kuzmine, A., & Shoshan‐Barmatz, V. (2024) · Biomolecules · doi:10.3390/biom14101304 · Cited by 23
Intrinsic aerobic capacity modulates Alzheimer’s disease pathological hallmarks, brain mitochondrial function and proteome during aging
Kugler, B. A., Lysaker, C. R., Franczak, E., Hauger, B. M., Csikós, V., Stopperan, J. A., Allen, J., Stanford, J. A., Koch, L. G., Britton, S. L., et al. (2024) · GeroScience · doi:10.1007/s11357-024-01248-3 · Cited by 17
Targeting the alternative oxidase (AOX) for human health and food security, a pharmaceutical and agrochemical target or a rescue mechanism?
Szibor, M., Schenkl, C., Barsottini, M. R. D. O., Young, L., & Moore, A. L. (2022) · Biochemical Journal · doi:10.1042/bcj20180192 · Cited by 15
Intracellular Ion Channel CLIC1: Involvement in Microglia-Mediated β-Amyloid Peptide(1-42) Neurotoxicity
Skaper, S. D., Facci, L., & Giusti, P. (2013) · Neurochemical Research · doi:10.1007/s11064-013-1084-2 · Cited by 16
“genase [65] and cytochrome oxidase activities [66] has been found in the brain and other tissues in AD.”
Background
Novel alkyl chain-based fluorescent probes with large Stokes shifts used for imaging the cell membrane and mitochondria in different living cell lines
Meng, F., Liu, Y., Niu, J., et al. (2017) · RSC Advances · doi:10.1039/c7ra00661f · Cited by 15
Role of Mitochondrial DNA Modifications in Degenerative Diseases and Aging
Richter, C. (1994) · Current topics in bioenergetics · doi:10.1016/b978-0-12-152517-0.50006-2 · Cited by 16
Mitochondrial DNA and Genetic Disease
Poulton, J. (1993) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.1993.tb11736.x · Cited by 15
Mitochondrial dysfunction in neurodegenerative disorders and aging
Schapira, A. H. V. (1994) · Elsevier eBooks · doi:10.1016/b978-0-7506-0585-4.50017-4 · Cited by 18
A comparison of single nucleotide primer extension with mispairing PCR-RFLP in detecting a point mutation
Lin, F. H., & Lin, R. J. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)92332-r · Cited by 15
A disease-modifying treatment for Alzheimer’s disease: focus on the trans-sulfuration pathway
Berry, T. M., Hamza, E. A., & Moustafa, A. A. (2019) · Reviews in the Neurosciences · doi:10.1515/revneuro-2019-0076 · Cited by 14
Estrés oxidativo y enfermedad de Alzheimer
Jiménez, F. J. J., Navarro, H. A., Ayuso‐Peralta, L., & Wadih, T. J. (2006) · Revista de Neurología · doi:10.33588/rn.4207.2005225 · Cited by 14
Amphiphilic α-tocopherol analogues as inhibitors of brain lipid peroxidation
Bolkenius, F. N., Verne-Mismer, J., Wagner, J., et al. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00768-7 · Cited by 14
Mitochondrial respiratory chain in brain homogenates: activities in different brain areas in patients with Alzheimer’s disease
Casademont, J., Rodríguez‐Santiago, B., Miró, Ò., Beato, A., López, S., Nunes, V., & Cardellach, F. (2005) · Aging Clinical and Experimental Research · doi:10.1007/bf03337713 · Cited by 14
Mitochondrial Myopathies: Genetic Aspects
Ballinger, S. W., Shoffner, J. M., & Wallace, D. C. (1994) · Current topics in bioenergetics · doi:10.1016/b978-0-12-152517-0.50008-6 · Cited by 14
Brain Mitochondria as a Therapeutic Target for Carnosic Acid
Infantino, V., Pappalardo, I., Santarsiero, A., Tripathi, S., Singh, G., & de Oliveira, M. R. (2024) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2303053 · Cited by 13
“Deficiency in complex IV and citrate synthase activities have also been found in AD patients [76,77].”
Phytochemicals, Antioxidants, and Cholinesterase Inhibitory Profiles of Elatostema Papillosum Leaves: An Alternative Approach for Management of Alzheimer's Disease
Alam, K. (2018) · Journal of Neurology and Neuromedicine · doi:10.29245/2572.942x/2018/5.1211 · Cited by 13
Cytochrome Oxidase Inhibition In Alzheimer’s Disease
Gonzalez-Lima, F., Valla, J. E., & Jorandby, L. (1998) · Springer eBooks · doi:10.1007/978-1-4757-9936-1_6 · Cited by 13
Isolation of a cytochrome oxidase gene overexpressed in Alzheimer's disease brain
Alberts, M. J., Ioannou, P. A., Deucher, R., Gilbert, J. R., Lee, J., Middleton, L. T., & Roses, A. D. (1992) · Molecular and Cellular Neuroscience · doi:10.1016/1044-7431(92)90057-9 · Cited by 13
Neuroprotective mechanism of trans,trans-Farnesol in an ICV-STZ-induced rat model of Alzheimer’s pathology
Kadian, M., Saini, N., Khera, A., & Kumar, A. (2024) · Inflammopharmacology · doi:10.1007/s10787-023-01413-8 · Cited by 12
“These enzymes are cytochrome-oxidase (complex IV) (Parker et al. 1990; Mutisya et al. 1994; Maurer et al. 2000), pyruvate dehydrogenase, and the oxoglutarate dehydrogenase complex (Gibson et al. 2010).”
Dendrimers—Novel Therapeutic Approaches for Alzheimer’s Disease
Mroziak, M., Kozłowski, G., Kołodziejczyk, W., Pszczołowska, M., Walczak, K., Beszłej, J. A., & Leszek, J. (2024) · Biomedicines · doi:10.3390/biomedicines12081899 · Cited by 12
“The decreased enzyme activity of mitochondrial enzymes in AD patients was found, especially cytochrome oxidase [20] in the frontal and cortical lobes [21].”
Background
Tau phosphorylation and OPA1 proteolysis are unrelated events: Implications for Alzheimer's Disease
Alavi, M. V. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2021.119116 · Cited by 12
Peripheral Markers and Diagnostic Criteria in Alzheimer's Disease: Critical Evaluations
de Lustig, E. S., Kohan, S., Famulari, A. L., Domínguez, R. O., & Serra, J. A. (1994) · Reviews in the Neurosciences · doi:10.1515/revneuro.1994.5.3.213 · Cited by 12
Parkinson's disease and the electron transport chain
Boyson, S. J. (1991) · Annals of Neurology · doi:10.1002/ana.410300303 · Cited by 12
The role of mitochondrial remodeling in neurodegenerative diseases
Guan, D., Liang, C., Zheng, D., Liu, S., Luo, J., Cai, Z., Zhang, H., & Chen, J. (2025) · Neurochemistry International · doi:10.1016/j.neuint.2024.105927 · Cited by 11
The concept of FDG-PET endophenotype in Alzheimer’s disease
During, E., Osorio, R. S., Elahi, F. M., Mosconi, L., & de Leon, M. J. (2011) · Neurological Sciences · doi:10.1007/s10072-011-0633-1 · Cited by 14
“(ROS) production, as a consequence of reduced cytochrome oxidase (COX) activity [79, 80], which also may enhance Aß toxicity [81].”
Quantitative Cytochrome Oxidase Histochemistry: Applications in Human Alzheimer's Disease and Animal Models
Valla, J., Schneider, L. E., Small, A. M., & Gonzalez-Lima, F. (2007) · Journal of Histotechnology · doi:10.1179/his.2007.30.4.235 · Cited by 11
The Role of Oxidative Processes and Metal Ions in Aging and Alzheimer’s Disease
Shinobu, L. A., & Beal, M. F. (1997) · Springer eBooks · doi:10.1007/978-1-4899-0197-2_13 · Cited by 12
Localization of cytochrome oxidase (COX) activity and COX mRNA in the perirhinal and superior temporal sulci of the monkey brain
Chandrasekaran, K., Stoll, J., Rapoport, S. I., & Brady, D. R. (1993) · Brain Research · doi:10.1016/0006-8993(93)90987-x · Cited by 10
Mitochondrial genome mutations and kidney disease
Singh, P. J., Santella, R. N., & Zawada, E. T. (1996) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(96)90144-4 · Cited by 11
Emerging Promise of Therapeutic Approaches Targeting Mitochondria in Neurodegenerative Disorders
Rahman, M. M., Tumpa, M. A. A., Rahaman, M. S., Islam, F., Sutradhar, P. R., Ahmed, M., Alghamdi, B. S. A., Hafeez, A., Alexiou, A. T., Perveen, A., et al. (2023) · Current Neuropharmacology · doi:10.2174/1570159x21666230316150559 · Cited by 11
Therapeutic Approaches to Delay the Onset of Alzheimer's Disease
Kumar, R., & Atamna, H. (2011) · Journal of Aging Research · doi:10.4061/2011/820903 · Cited by 10
“The potential significance of combining diaminophenothiazins and osmolytes to treat AD is discussed.”
Background
Inhibition of energy metabolism down-regulates the Alzheimer related presenilin 2 gene
Ghidoni, R., Gasparini, L., Alberici, A., et al. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-003-0015-9 · Cited by 10
Unaltered cytochrome oxidase, glutamate dehydrogenase and glutaminase activities in platelets from patients with Sporadic Amyotrophic Lateral Sclerosis
Gluck, M. R., Thomas, R. G., & Sivak, M. A. (2000) · Journal of Neural Transmission · doi:10.1007/s007020070007 · Cited by 10
“In this series of studies reduced cytochrome oxidase activity in postmortem AD brain tissue correlated with decreased platelet and cybrid cytochrome oxidase activities from living AD patients (Parker et al., 1990, 1994).”
Background
Insights from Drosophila on Aβ- and tau-induced mitochondrial dysfunction: mechanisms and tools
Varte, V., Munkelwitz, J. W., & Rincón-Limas, D. E. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1184080 · Cited by 9
“Brains from AD patients show decreased production of ATP, increased production of free radicals, lipid peroxidation, oxidative damage of DNA and protein, and cellular damage compared to control specimens (Parker et al., 1990; Gibson et al., 1998; Maurer et al., 2000; Wang et al., 2005; Devi et al., 2006; Dragicevic et…”
Background
Unraveling the mystery of citrate transporters in Alzheimer’s disease: An updated review
Mukherjee, A. G., Mishra, S., Gopalakrishnan, A. V., Kannampuzha, S., Murali, R., Wanjari, U. R., Stany, B. K., Vellingiri, B., Madhyastha, H., Deepankumar, K., et al. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102726 · Cited by 11
Some Remarks on Biological Markers of Alzheimer’s Disease
Robles, A. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00011-6 · Cited by 9
The T9861C Mutation in the mtDNA-Encoded Cytochrome C Oxidase Subunit III Gene Occurs in High Frequency but with Unequal Distribution in the Alzheimer’s Disease Brain
Castora, F. J., Conyers, B., Gershon, B. S., Kerns, K. A., Robert Campbell, & Simsek‐Duran, F. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190176 · Cited by 9
Insulin and Insulin-Sensitizing Drugs in Neurodegeneration: Mitochondria as Therapeutic Targets
Cardoso, S., Santos, R. X., Correia, S. C., Carvalho, C., Zhu, X., Lee, H., Casadesús, G., Smith, M. A., Perry, G. L., & Moreira, P. I. (2009) · Pharmaceuticals · doi:10.3390/ph2030250 · Cited by 10
“Deficient COX activity has been found in different brain regions [73,74], platelets [75] and fibroblasts [76] from sporadic AD patients, occurring at all stages of the disease, including mild cognitive impairment (MCI) [77].”
Background
PET sheds light on Alzheimer's disease genetic risk
Swerdlow, R. H. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709690104 · Cited by 10
Targeting mitochondrial dysfunction in Alzheimer's disease: New findings and perspectives
Hroudová, J., & Fišar, Z. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111491 · Cited by 9
Heat Therapy: Targeting Health, Disease, and Disability
Richey, R. E., Hyldahl, R. D., Kaiser, B. W., Geiger, P. C., Halliwill, J. R., & Minson, C. T. (2026) · Comprehensive physiology · doi:10.1002/cph4.70089 · Cited by 11
Differential pathlength factor informs evoked stimulus response in a mouse model of Alzheimer’s disease
Lin, A. J., Ponticorvo, A., Durkin, A. J., Venugopalan, V., Choi, B., & Tromberg, B. J. (2015) · Neurophotonics · doi:10.1117/1.nph.2.4.045001 · Cited by 8
Molecular Neurobiology of Retinal Degeneration
Sharma, R. (2007) · Springer eBooks · doi:10.1007/978-0-387-30374-1_3 · Cited by 9
Brain Cytochrome Oxidase Activity and How it Relates to the Pathophysiology of Memory and Alzheimer’s Disease
Gonzalez-Lima, F., Valla, J. E., & Cada, A. M. (1998) · Springer eBooks · doi:10.1007/978-1-4757-2907-8_20 · Cited by 8
Alteration of human platelet protein kinase C with normal aging
Matsushima, H., Shimohama, S., Yamaoka, Y., et al. (1993) · Mechanisms of Ageing and Development · doi:10.1016/0047-6374(93)90077-5 · Cited by 8
Disturbances of Copper Homeostasis and Brain Function
Rotilio, G., Ciriolo, M. R., Carrı̀, M. T., & Rossi, L. C. (2002) · Humana Press eBooks · doi:10.1007/978-1-59259-288-3_16 · Cited by 7
Exploring mitochondrial blood-based and genetic markers in older adults with mild cognitive impairment and remitted major depressive disorder
Choi, J., Beroncal, E. L., Chernega, T., Brooks, H., Kennedy, J. L., Fisher, C. E., Flint, A. J., Herrmann, N., Lanctôt, K. L., Mah, L., et al. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03155-9 · Cited by 8
Relationships between gene expression and behavior in mice in response to systemic modulation of the O‐GlcNAcylation pathway
Bell, M. B., Ouyang, X., Shelton, A., Huynh, N. V., Mueller, T., Chacko, B. K., Jegga, A. G., Chatham, J. C., Miller, C. R., Darley-Usmar, V. M., et al. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15835 · Cited by 7
“…transcription, metabolism, and cell signaling (Alonso et al., 2014; Bond & Hanover, 2013; Darley- Usmar et al., 2012; Hardiville & Hart, 2014; Love & Hanover, 2005; Marsh et al., 2014; Mueller et al., 2021; Paruchuri & Zachara, 2011; Slawson et al., 2006; Wani et al., 2015; Zachara & Hart, 2004).”
Trends of mitochondrial changes in AD: a bibliometric study
Song, R., Guo, Y., Fu, Y., Ren, H., Wang, H., Yan, H., & Ge, Y. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1136400 · Cited by 7
“, 2006), the cytochrome C oxidase deficiency (Parker et al., 1990), modulation of the endoplasmic reticulum-mitochondria interface and high levels of mitochondrial DNA deletions in substantia nigra neurons (De Brito and Scorrano, 2008; Louise et al.”
Background
Mitochondrial Medicine
Wallace, D. C., Lott, M. T., & Procaccio, V. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-383834-6.00013-6 · Cited by 8
Mitochondria in Neurodegeneration
Swerdlow, R. H. (2011) · Advances in neurobiology · doi:10.1007/978-1-4614-1788-0_30 · Cited by 7
Platelets in Alzheimer’s Disease
Plagg, B., & Humpel, C. (2015) · InTech eBooks · doi:10.5772/60535 · Cited by 7
Effects of Sodium Azide on Motor Activity, Motor Coordination, and Learning
Lalonde, R., Joyal, C. C., & Beaudin, S. A. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00158-x · Cited by 7
Alzheimer's disease, estrogens, and clinical trials: a case study in drug development for complex disorders
Howell, N., Dykens, J. A., & Moos, W. H. (2005) · Drug Development Research · doi:10.1002/ddr.20046 · Cited by 7
Mitochondrial Myopathies: Biochemical Aspects
Shanske, S., & DiMauro, S. (1994) · Current topics in bioenergetics · doi:10.1016/b978-0-12-152517-0.50007-4 · Cited by 7
Bioenergetics and excitotoxicity
Greene, J. G., & Greenamyre, J. T. (1996) · Elsevier eBooks · doi:10.1016/b978-012525445-8/50010-2 · Cited by 7
Aβ Oligomers-Induced Toxicity is Attenuated in Cells Cultured with NbActiv4™ Medium
Zhou, Y., & Klein, W. L. (2012) · Neurotoxicity Research · doi:10.1007/s12640-012-9318-7 · Cited by 6
Antioxidant modulation in restoring mitochondrial function in neurodegeneration
Arrozi, A. P., Ngah, W. Z. W., Yusof, Y. A. M., Damanhuri, H. A., & Makpol, S. (2016) · International Journal of Neuroscience · doi:10.1080/00207454.2016.1178261 · Cited by 7
Cortical neurons transgenic for human Abeta40 or Abeta42 have similar vulnerability to apoptosis despite their different amyloidogenic properties.
Shiwany, N. A., Xie, J., & Guo, Q. (2009) · PubMed Central · Cited by 6
LAMININ STIMULATES EXPRESSION OF TWO MITOCHONDRIAL PROTEINS DURING NEURITE OUTGROWTH
Weeks, B. S., Burbelo, P. D., Jucker, M., et al. (1996) · International Journal of Developmental Neuroscience · doi:10.1016/0736-5748(96)00019-6 · Cited by 6
Protective Effects of Daidzein on Oxidative Stress‐Induced Neurotoxicity and Scopolamine‐Mediated Cognitive Defect
Jin, H., Kim, M., Young-Min, S. U. H., Choi, S. J., Nam Shik, M. U. N., Kim, H. K., Kim, E. K., & Shin, D. H. (2005) · Journal of Food Science · doi:10.1111/j.1365-2621.2005.tb07122.x · Cited by 6
Energy/Glucose Metabolism in Neurodegenerative Diseases
Blass, J. P. (1997) · Humana Press eBooks · doi:10.1007/978-1-59259-471-9_7 · Cited by 6

Authors: Parker, W. D., Filley, C. M., & Parks, J. K.
Affiliations: University of Colorado Denver (US)
ORCID: Filley, Christopher M.
Venue: Neurology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 1990-08
Volume: 40
Issue: 8
Pages: 1302-1302
ISSN: 0028-3878 (ISSN-L)
1526-632X
DOI: 10.1212/wnl.40.8.1302
OpenAlex: W1988731658
Cited by: 598
References: 0
Citations by year: 2026: 19 · 2025: 10 · 2024: 12 · 2023: 20 · 2022: 9 · 2021: 22 · 2020: 25 · 2019: 19 · 2018: 18 · 2017: 18 · 2016: 28 · 2015: 10 · 2014: 10 · 2013: 21 · 2012: 15
FWCI: 7.27
Type: journal article
Language: en
Open access: closed
Locations: Neurology (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (7r01ns025382-06)
National Institute of Neurological Disorders and Stroke (NS25382)
National Center for Research Resources (RR-69)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords: cytochrome oxidase deficiency, Alzheimer's disease, platelet mitochondria, electron transport chain, mitochondrial dysfunction, systemic disease
MeSH terms: Aged, Alzheimer Disease, Blood Platelets, Electron Transport Complex IV, Electron Transport, Female, Humans, Kinetics, Male, Mitochondria, Reference Values, Cytochrome-c Oxidase Deficiency

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cytochrome oxidase deficiency in Alzheimer’s disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cited by

Related

Metadata

Record

About these checks